Average Co-Inventor Count = 3.25
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Autifony Therapeutics Limited (21 from 25 patents)
2. Nerre Therapeutics Limited (3 from 9 patents)
3. Glaxo Wellcome Manufacturing Pte Ltd (2 from 2 patents)
4. Convergence Pharmaceuticals Limited (1 from 24 patents)
5. Autifony Therapeuctics Limited (1 from 1 patent)
6. Glaxo Group Limited (1,168 patents)
28 patents:
1. 11583527 - Hydantoin derivatives useful as Kv3 inhibitors
2. 11541052 - Compounds
3. 11197859 - Hydantoin derivatives useful as Kv3 inhibitors
4. 11180461 - Triazoles as Kv3 inhibitors
5. 10934278 - Compounds
6. 10835534 - Compounds
7. 10632118 - Imidazolidinedione derivatives
8. 10611735 - Triazoles as Kv3 inhibitors
9. 10555945 - Compounds
10. 10265316 - Hydantoin derivatives useful as Kv3 inhibitors
11. 10160730 - Triazoles as KV3 inhibitors
12. 10098881 - Compounds
13. 10058551 - Imidazolidinedione derivatives
14. 9849131 - Imidazolidinedione derivatives
15. 9833452 - Compounds